Register Login
Register to leave comments
  • News bot Jan. 6, 2026, 1:05 p.m.

    📋 Compass Therapeutics, Inc. (CMPX) - Clinical Trial Update

    Filing Date: 2026-01-06

    Accepted: 2026-01-06 08:00:54

    Event Type: Clinical Trial Update

    Event Details:

    Compass Therapeutics Inc. (CMPX) Announces Clinical Trial Update Compass Therapeutics Inc. (CMPX) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: observed, expected
    • Clinical Stage: Phase 1 study, Phase 2
    • Collaboration: Company
    • Updated Timeline: late Q1 2026, Q1 2026
      • expected in H2 2026
      • expected in Q1 2026
      • expected in H1 2026

    🔬 Clinical Development Pipeline (Compass Therapeutics, Inc.):

    Product Type Development Stage Therapeutic Area Source
    CTX-8371 DRUG Phase PHASE1 Non Small Cell Lung Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Compass Therapeutics Inc.
    • CIK: 0001738021
    • Ticker Symbol: CMPX
    • Period End Date: 2026-01-06
    • Document Type: 8-K

Search

News categories